202 related articles for article (PubMed ID: 28816971)
1. Combining of serial embolization and denosumab for large sacropelvic giant cell tumor: Case report of 3 cases.
Ji T; Yang Y; Wang Y; Sun K; Guo W
Medicine (Baltimore); 2017 Aug; 96(33):e7799. PubMed ID: 28816971
[TBL] [Abstract][Full Text] [Related]
2. The risk of neurological deterioration while using neoadjuvant denosumab on patients with giant cell tumor of the spine presenting with epidural disease: a meta-analysis of the literature.
Al Farii H; McChesney G; Patel SS; Rhines LD; Lewis VO; Bird JE
Spine J; 2024 Jun; 24(6):1056-1064. PubMed ID: 38301904
[TBL] [Abstract][Full Text] [Related]
3. A nonrandomized controlled study of sacral giant cell tumors with preoperative treatment of denosumab.
Yang Y; Li Y; Liu W; Xu H; Niu X
Medicine (Baltimore); 2018 Nov; 97(46):e13139. PubMed ID: 30431583
[TBL] [Abstract][Full Text] [Related]
4. Does Denosumab Change the Giant Cell Tumor Treatment Strategy? Lessons Learned From Early Experience.
Agarwal MG; Gundavda MK; Gupta R; Reddy R
Clin Orthop Relat Res; 2018 Sep; 476(9):1773-1782. PubMed ID: 30794215
[TBL] [Abstract][Full Text] [Related]
5. Selective Arterial Embolization for the Treatment of Sacral and Pelvic Giant Cell Tumor: A Systematic Review.
He SH; Xu W; Sun ZW; Liu WB; Liu YJ; Wei HF; Xiao JR
Orthop Surg; 2017 May; 9(2):139-144. PubMed ID: 28644557
[TBL] [Abstract][Full Text] [Related]
6. Treatment of a skull-base giant cell tumor with endoscopic endonasal resection and denosumab: case report.
Goto Y; Furuno Y; Kawabe T; Ohwada K; Tatsuzawa K; Sasajima H; Hashimoto N
J Neurosurg; 2017 Feb; 126(2):431-434. PubMed ID: 27177173
[TBL] [Abstract][Full Text] [Related]
7. Retrospective cohort study of 68 sacral giant cell tumours treated with nerve-sparing surgery and evaluation on therapeutic benefits of denosumab therapy.
Lim CY; Liu X; He F; Liang H; Yang Y; Ji T; Yang R; Guo W
Bone Joint J; 2020 Feb; 102-B(2):177-185. PubMed ID: 32009426
[TBL] [Abstract][Full Text] [Related]
8. Giant cell tumor of the sacrum and spine: series of 23 cases and a review of the literature.
Martin C; McCarthy EF
Iowa Orthop J; 2010; 30():69-75. PubMed ID: 21045974
[TBL] [Abstract][Full Text] [Related]
9. Use of Denosumab and Serial Arterial Embolization Combination Therapy as an Alternative to Surgical Resection in a Case of Large Sacro-Pelvic Giant Cell Tumor.
Gupta K; Jain AP; Ahuja K; Mittal S; Kandwal P
Neurol India; 2023; 71(2):345-348. PubMed ID: 37148070
[No Abstract] [Full Text] [Related]
10. Clinicopathological Features of a Series of 27 Cases of Post-Denosumab Treated Giant Cell Tumors of Bones: A Single Institutional Experience at a Tertiary Cancer Referral Centre, India.
Rekhi B; Verma V; Gulia A; Jambhekar NA; Desai S; Juvekar SL; Bajpai J; Puri A
Pathol Oncol Res; 2017 Jan; 23(1):157-164. PubMed ID: 27722984
[TBL] [Abstract][Full Text] [Related]
11. Serial arterial embolization for large sacral giant-cell tumors: mid- to long-term results.
Hosalkar HS; Jones KJ; King JJ; Lackman RD
Spine (Phila Pa 1976); 2007 May; 32(10):1107-15. PubMed ID: 17471094
[TBL] [Abstract][Full Text] [Related]
12. Denosumab in giant cell tumour of bone in the pelvis and sacrum: Long-term therapy or bone resection?
Sambri A; Medellin MR; Errani C; Campanacci L; Fujiwara T; Donati D; Parry M; Grimer R
J Orthop Sci; 2020 May; 25(3):513-519. PubMed ID: 31155442
[TBL] [Abstract][Full Text] [Related]
13. Short-term Preoperative Denosumab With Surgery in Unresectable or Recurrent Giant Cell Tumor of Bone.
Zhang RZ; Ma TX; Qi DW; Zhao M; Hu T; Zhang GC
Orthop Surg; 2019 Dec; 11(6):1101-1108. PubMed ID: 31762217
[TBL] [Abstract][Full Text] [Related]
14. Denosumab-treated Giant Cell Tumor of Bone Exhibits Morphologic Overlap With Malignant Giant Cell Tumor of Bone.
Wojcik J; Rosenberg AE; Bredella MA; Choy E; Hornicek FJ; Nielsen GP; Deshpande V
Am J Surg Pathol; 2016 Jan; 40(1):72-80. PubMed ID: 26414220
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive treatment for multicentric giant cell tumors of the pelvis and spine using apatinib: A case report and literature review.
Li J; Zhou J; Liu Y; Sun X; Song W
J Cancer Res Ther; 2020 Sep; 16(5):1020-1026. PubMed ID: 33004743
[TBL] [Abstract][Full Text] [Related]
16. Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.
Yayan J
Cancer Control; 2020; 27(3):1073274820934822. PubMed ID: 32869648
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment with denosumab in a patient with sacral giant cell tumor of bone refractory to combination therapy with arterial embolization and zoledronic acid: A case report.
Nishimura S; Hashimoto K; Tan A; Yagyu Y; Akagi M
Mol Clin Oncol; 2017 Mar; 6(3):307-310. PubMed ID: 28451403
[TBL] [Abstract][Full Text] [Related]
18. Denosumab: non-surgical treatment option for selective arterial embolization resistant aneurysmal bone cyst of the spine and sacrum. Case report.
Ghermandi R; Terzi S; Gasbarrini A; Boriani S
Eur Rev Med Pharmacol Sci; 2016 Sep; 20(17):3692-5. PubMed ID: 27649673
[TBL] [Abstract][Full Text] [Related]
19. Role of Denosumab in Endoscopic Endonasal Treatment for Juvenile Clival Giant Cell Tumor: A Case Report and Review of the Literature.
Inoue A; Ohnishi T; Kohno S; Nishikawa M; Nishida N; Ohue S
World Neurosurg; 2016 Jul; 91():674.e1-6. PubMed ID: 27113403
[TBL] [Abstract][Full Text] [Related]
20. The multidisciplinary management of giant cell tumor of bone.
Ng VY; Davidson DJ; Kim EY; Pollack SM; Conrad Iii EU; Jones RL
Expert Rev Anticancer Ther; 2014 Jul; 14(7):783-90. PubMed ID: 24666240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
